Tom Oliverson, M.D., a Republican member of the Texas State House representing the 130th district since 2017, posted a series of tweets on May 8, 2026, addressing concerns about pharmaceutical industry practices and reacting to related news.
In one post at 22:51 UTC, Oliverson commented, “Good grief. https://t.co/mmmcIVM03d”.
Later that evening at 23:41 UTC, he addressed the issue of generic drug competition and brand-name manufacturer tactics by stating, “The expiration of exclusivity is frustrated with shenanigans like “pay to delay” (where the brand name manufacturer pays the generic manufacturer not to manufacture) and “patent thicket” (where the brand name manufacturer places hundreds of separate patents on the drug making https://t.co/DtDlOILxp6”.
At 23:49 UTC, Oliverson followed up with another reactionary post: “Hahahahahahahahahahahahahaha! https://t.co/laZBT7Bb4t”.
Oliverson has served in the Texas State House since his election in 2017. He succeeded Allen Fletcher as representative for District 130.
